Beyond the Scope: Breast Biomarkers in the Digital Age

This lecture explores advancements in breast cancer biomarker analysis, focusing on the integration of digital pathology and emerging technologies. Beginning with a review of key biomarkers like ER/PR, HER2, Ki-67, and PD-L1, it delves into their clinical significance, testing methodologies, and associated challenges. The session further introduces digital pathology, highlighting benefits such as enhanced accessibility and collaboration, and concludes with insights into future trends,...